Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.73B |
| 2 |
XYZ
Block Inc
XYZ
|
+$672M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$586M |
| 4 |
Mirion Technologies
MIR
|
+$572M |
| 5 |
Zscaler
ZS
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.21B |
| 2 |
Microsoft
MSFT
|
+$1.05B |
| 3 |
Meta Platforms (Facebook)
META
|
+$685M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$545M |
| 5 |
Tesla
TSLA
|
+$537M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.68% |
| 2 | Consumer Discretionary | 9% |
| 3 | Financials | 7.65% |
| 4 | Healthcare | 7.34% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Iovance Biotherapeutics
IOVA
$1.95B
| $27.7M | 0.01% |
1,449,804
+194,704
| +16% | +$4.29M |
|
1827
Vanguard Russell 1000 Growth ETF
VONG
$44.9B
| $27.7M | 0.01% |
352,061
+96,929
| +38% | +$7.39M |
|
1828
Wabtec
WAB
$50.5B
| $27.6M | 0.01% |
299,526
-43,190
| -13% | -$3.96M |
|
1829
Acadia Pharmaceuticals
ACAD
$4.65B
| $27.6M | 0.01% |
1,181,923
+355,077
| +43% | +$7.14M |
|
1830
NCR Voyix
VYX
$1.22B
| $27.6M | 0.01% |
1,118,167
+491,641
| +78% | +$12.5M |
|
1831
XPO
XPO
$23.8B
| $27.5M | 0.01% |
598,364
-1,369,204
| -70% | -$63.6M |
|
1832
Zillow
ZG
$8.47B
| $27.5M | 0.01% |
442,304
+196,003
| +80% | +$14.1M |
|
1833
Cameco
CCJ
$40.5B
| $27.5M | 0.01% |
1,259,502
-1,389,567
| -52% | -$33.6M |
|
1834
CALL
Eli Lilly
LLY
$995B
| $27.5M | 0.01% |
99,400
+49,900
| +101% | +$12.6M |
|
|
SNV
1835
DELISTED
Synovus
SNV
| $27.4M | 0.01% |
573,184
-1,162
| -0.2% | -$55K |
|
|
WIRE
1836
DELISTED
Encore Wire Corp
WIRE
| $27.3M | 0.01% |
191,025
-5,156
| -3% | -$667K |
|
1837
Certara
CERT
$1.21B
| $27.3M | 0.01% |
958,856
-199,890
| -17% | -$6.72M |
|
1838
Allogene Therapeutics
ALLO
$656M
| $27.2M | 0.01% |
1,823,265
-156,447
| -8% | -$2.76M |
|
1839
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
| $27.2M | 0.01% |
434,555
+20,013
| +5% | +$1.26M |
|
1840
Churchill Downs
CHDN
$5.95B
| $27.2M | 0.01% |
225,600
+71,064
| +46% | +$8.44M |
|
1841
Encompass Health
EHC
$11B
| $27.2M | 0.01% |
522,986
+112,036
| +27% | +$5.78M |
|
1842
DaVita
DVA
$14.6B
| $27.1M | 0.01% |
238,278
-148,205
| -38% | -$15.9M |
|
|
JKS
1843
JinkoSolar
JKS
$837M
| $27.1M | 0.01% |
589,730
-310,256
| -34% | -$16M |
|
1844
Zai Lab
ZLAB
$2.09B
| $27.1M | 0.01% |
431,243
+166,739
| +63% | +$14.1M |
|
1845
On Holding
ONON
$12.5B
| $27.1M | 0.01% |
716,431
+333,118
| +87% | +$12.2M |
|
|
SWN
1846
DELISTED
Southwestern Energy Company
SWN
| $27M | 0.01% |
5,787,183
+2,456,061
| +74% | +$12.2M |
|
|
TUYA
1847
Tuya Inc
TUYA
$1.07B
| $27M | 0.01% |
4,313,981
+4,143,367
| +2,429% | +$28.1M |
|
|
VRNT
1848
DELISTED
Verint Systems
VRNT
| $26.9M | 0.01% |
512,679
+103,160
| +25% | +$4.95M |
|
1849
Bentley Systems
BSY
$11B
| $26.9M | 0.01% |
556,422
+230,790
| +71% | +$12.5M |
|
|
SAVE
1850
DELISTED
Spirit Airlines, Inc.
SAVE
| $26.9M | 0.01% |
1,230,685
+935,971
| +318% | +$21.7M |
|
Similar funds
Goldman Sachs's Q4 2021 Portfolio in Review
As of Q4 2021, Goldman Sachs held 6,959 positions worth $504B, up 6.8% from $471B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q4 2021 filing shows 774 new, 2,659 increased, 2,316 reduced and 526 closed positions. Its largest new stake was Mirion Technologies: 53,265,743 shares worth $558M. The largest sale was Alibaba, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- Goldman Sachs's largest Q4 2021 buy was Mirion Technologies: 53,265,743 shares worth $558M.
- Goldman Sachs added most to Invesco QQQ Trust in Q4 2021, an estimated $1.73B increase.
- Goldman Sachs's biggest Q4 2021 reduction was Alibaba, cutting an estimated $1.21B.
- Goldman Sachs fully exited PPD, Inc. Common Stock in Q4 2021, selling an estimated $277M.
- Goldman Sachs's ten largest holdings make up 18% of its $504B portfolio in Q4 2021.
- Goldman Sachs opened 774 new positions and closed 526 in Q4 2021.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $504B.
Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.